en · de · es · pt
cjc-1295-notes.peptides7250.com › Topic › Identity And Naming History — Hands-On Walkthrough

Identity And Naming History — Hands-On Walkthrough

By Editorial Desk · published 2026-06-01 · last reviewed 2026-07-06 · Topic

DAC group comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Last reviewed on 2026-07-06. Where a claim depends on a specific study, the study is described rather than over-claimed.

Identity and Naming History

The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.

Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.

CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.

Receptor Action and Clearance

Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.

Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.

Cjc-1295 at a glance

PropertyValueNotes
Molecular classSynthetic peptideGHRH analog, not a steroid
Backbone length29 amino acidsBased on GRF(1-29)
SubstitutionsFour positionsD-Ala2, Gln8, Ala15, Leu27
AppearanceWhite to off-white powderTypical lyophilized research material
Common synonymsModified GRF(1-29)Usage varies between sources

Persistence, Stability and Measurement

Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.

Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.

The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.

Related pages on this site

Mechanism and Pharmacokinetics

Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.

Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.

The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.

Background and Naming Conventions

The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.

Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.

Background and Molecular Design

CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.

Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.

Further detail

=== By other insects === Honey bees are not the only eusocial insects to produce honey. All non-parasitic bumblebees and stingless bees produce honey. Some wasp species, such as Brachygastra lecheguana and Brachygastra mellifica, found in South and Central America, are known to feed on nectar and produce honey. Other wasps, such as Polistes versicolor, also consume honey. In the middle of their life cycles they alternate between feeding on protein-rich pollen and feeding on honey, which is a far denser source of food energy.

== Detection in humans == Two principal techniques have been used most often to detect levels of aflatoxin in humans, though they are not commercially available. The first method is measuring the AFB1-guanine adduct in the urine of subjects. The presence of this breakdown product indicates exposure to aflatoxin B1 during the past 24 hours. This technique measures only recent exposure, however. Due to the half-life of this metabolite, the level of AFB1-guanine measured may vary from day to day, based on diet, and it is not ideal for assessing long-term exposure. Another technique that has been used is a measurement of the AFB1-albumin adduct level in the blood serum. This approach provides a more integrated measure of exposure over several weeks or months.

Under Wenger, Arsenal reached their first UEFA Champions League final in 2006 and relocated from Highbury to the Emirates Stadium. Financial constraints following the move contributed to a nine-year trophy drought, though Wenger later guided the club to further FA Cup victories in the 2010s, becoming the competition's most successful manager with seven wins. He stepped down as Arsenal manager in 2018 and retired from club management. Wenger is credited with reshaping English football culture and modernising the managerial profession, though his teams were occasionally criticised for tactical naivety and disciplinary issues. Wenger is also noted for his emphasis on youth development and talent identification throughout his career.

Sources: en.wikipedia.org

Supporting material

== History == The compound may have been synthesised by either Jābir ibn Hayyān in the 8th century or Ramon Llull in 1275. It was synthesised in 1540 by Valerius Cordus, who called it "sweet oil of vitriol" (oleum dulce vitrioli) – the name reflects the fact that it is obtained by distilling a mixture of ethanol and sulfuric acid (then known as oil of vitriol) – and noted some of its medicinal properties. At about the same time, Paracelsus discovered the analgesic properties of the molecule in dogs. The name ether was given to the substance in 1729 by August Sigmund Frobenius. It was considered to be a sulfur compound until the idea was disproved in about 1800. The synthesis of diethyl ether by a reaction between ethanol and sulfuric acid has been known since the 13th century.

Tanaka Team have developed a diagnostic technology that enables early detection of diseases from a small amount of blood. By artificially modifying antibodies with polyethylene glycol at their base, the arms can move like springs, allowing simultaneous binding to antigens. In experiments with protein fragments related to Alzheimer's disease, the modified antibodies captured antigens more than 100 times more strongly than conventional antibodies. Later improvements enabled glycan analysis from trace mixed samples without peptide selection, leading to the detection of Alzheimer’s-related proteins from 1 mL of blood and the identification of eight previously unknown related substances. This technology is expected to contribute to the early detection of various diseases, including Alzheimer’s disease and prostate cancer. The research originated from work awarded the Nobel Prize in 2002, though the initial methods lacked sufficient sensitivity for medical applications. In 2009, it was selected for the FIRST Program, Development of Next-Generation Mass Spectrometry Systems and Contributions to Drug Discovery and Diagnosis, which provided about 4 billion yen over five years. With a team of around 60 researchers, a breakthrough analytical method was developed within a year, achieving up to a 10,000-fold increase in sensitivity. In November 2011, the team described the results as a technology applicable to early diagnosis and antibody-based drug development, publishing findings in the electronic edition of an English journal issued by the Japan Academy.

In Britain, think tanks play a similar role to the United States, attempting to shape policy, and indeed there is some cooperation between British and American think tanks. For example, the London-based think tank Chatham House and the Council on Foreign Relations were both conceived at the Paris Peace Conference, 1919 and have remained sister organisations. The Bow Group, founded in 1951, is the oldest centre-right think tank and many of its members have gone on to serve as Members of Parliament or Members of the European Parliament. Past chairmen have included Conservative Party leader Michael Howard, Margaret Thatcher's longest-serving Cabinet Minister Geoffrey Howe, Chancellor of the Exchequer Norman Lamont and former British Telecom chairman Christopher Bland. Since 2000, a number of influential centre-right think tanks have emerged including Policy Exchange, Centre for Social Justice and most recently Onward.

Nussio, Enzo; Ugarriza, Juan E. (2021). "Why Rebels Stop Fighting: Organizational Decline and Desertion in Colombia's Insurgency". International Security. 45 (4): 167–203. doi:10.1162/isec_a_00406. hdl:20.500.11850/480000. ISSN 0162-2889. Sherman, John W. "Political Violence in Colombia: Dirty Wars Since 1977." History Compass (Sep 2015) 13#9 pp 454–465. Cirlig, Carmen-Cristina. "Colombia: new momentum for peace?" (PDF). Library Briefing. Library of the European Parliament. Retrieved July 15, 2013. Azcarate, Camilo A. (March 1999). "Psychosocial Dynamics of the Armed Conflict in Colombia". Online Journal of Peace and Conflict Resolution. Archived from the original on January 6, 2003. James Petras (July 2, 1988). "Neglected Dimensions of Violence". Economic and Political Weekly. 23 (27): 1367. JSTOR 4378701. Elizabeth F. Schwartz (Winter 1995–1996). "Getting Away with Murder: Social Cleansing in Colombia and the Role of the United States". The University of Miami Inter-American Law Review. 27 (2): 381–420. John Lindsay-Poland (January–February 2010). "Retreat to Colombia: The Pentagon Adapts Its Latin America Strategy". NACLA Report on the Americas. Government/NGO reports

Sources: en.wikipedia.org

Notes from published material

The three substrates of this enzyme are L-valine, water, and oxidised nicotinamide adenine dinucleotide phosphate (NADP+). Its products are α-ketoisovaleric acid, reduced NADPH, ammonia, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-NH2 group of donors with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is L-valine:NADP+ oxidoreductase (deaminating). Other names in common use include valine dehydrogenase (nicotinamide adenine dinucleotide phosphate), and valine dehydrogenase (NADP+).

DC's Stargirl, or simply Stargirl, is an American superhero television series created by Geoff Johns that premiered on streaming service DC Universe. It is based on the DC Comics superhero Courtney Whitmore, created by Johns and Lee Moder. The series follows high school student Courtney Whitmore who discovers the cosmic staff originally wielded by Starman and becomes the inspiration for a new generation of superheroes who become the new incarnation of the Justice Society of America. DC Universe ordered the series in July 2018. Brec Bassinger was cast as Courtney Whitmore that September, with additional castings for her family members, the Justice Society of America, and the Injustice Society of America through February 2019. Filming for the series began in March 2019 in the Atlanta metropolitan area. Stargirl premiered on DC Universe on May 18, 2020; the first season consists of 13 episodes and also aired the following day on the broadcast network The CW. The second season, subtitled Summer School premiered on August 10, 2021, exclusively on The CW. The third and final season, subtitled Frenemies premiered on August 31, 2022. Ahead of the series premiere, characters from the series were featured in a cameo during the Arrowverse crossover "Crisis on Infinite Earths" through archive footage. It established Stargirl as existing on a parallel Earth to the Arrowverse. The show has received critical acclaim.

== Description == Among the distinguishing characters of the genus are two series of stamens totaling twice the number of petals; free or nearly free petals (not joined in a tube); a stout rhizome from whose axils the flowering stems rise; and a basal rosette of leaves. This genus contains the only species of Crassulaceae that have unisexual flowers.

After returning from the DL, Helton played only 6 games before announcing that he would have season-ending hip surgery in order to prepare for the 2013 season. Helton was healthier in 2013, playing in 124 games, while hitting 15 home runs with 61 RBIs. On September 14, 2013, Helton announced that he would be retiring at the conclusion of the 2013 season. On September 25, before his last game at Coors Field, Helton was honored by the Rockies in a pre-game ceremony. In the game, Helton hit a home run and drove in three runs versus the Boston Red Sox. On August 17, 2014, the Rockies retired Helton's number 17 before a game at Coors Field. He was the first Rockies player to have his number retired in the franchise's history.

=== Stimuli-responsive dextran micelles === Dextran micelles can be synthesized and modified to be stimuli-responsive. These stimuli include pH, temperature, and redox conditions. Micelles composed of dextran grafted with deoxycholic acid or polycaprolactone via a disulfide bond are responsive to a redox environment. Dextran micelles conjugated with cholesterol exhibit pH responsiveness when modified with histidine. Dextran-benzimidazole conjugate micelles also exhibit pH-responsiveness. When the polymeric micelles encounter these stimuli, release of the drug from the hydrophobic core is triggered by various mechanisms depending on the stimuli and the conjugated material. Stimuli-responsive dextran grafted micelles decrease off-site drug toxicity and increase localized drug concentration in the target site.

Sources: en.wikipedia.org

Frequently asked questions

Is this compound a naturally occurring hormone?

No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.

Why do two versions share one name?

The original material included a linker that binds serum albumin. A later variant removed that linker to reduce the duration of action. Catalogs and papers did not consistently adopt separate names, so both remain widely labeled with the same term.

What is the most reliable identifier?

The amino acid sequence and the presence or absence of the linker group. Mass measured by spectrometry gives an independent check that separates the two forms.

Which receptor does the compound target?

It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.

Network